Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone for Pain in Fibromyalgia
NCT02806440Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jun 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in fibromyalgia (FM), sponsored by Rigshospitalet. Started Jun 2016; status: completed.
02
Drugs
naltrexone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02806440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806440.